Medical device maker Medtronic on Tuesday reported a solid fiscal Q2, but its profit margins faced head winds as the company dealt with macroeconomic and regulatory challenges. Shares fell a fraction. For the quarter ended Oct. 25, Medtronic (MDT) made 91 cents a share, up 3.4% from the year-earlier quarter and a penny above analyst consensus. Sales rose 2.4% to $4.2 billion, in line with consensus. The company reiterated its guidance for the
See the article here:
Medtronic Reports Mixed Quarter In Transitional Year